Source: International Congress 2018 – COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Dalon (Lyon, France), N. Roche (Paris, France), M. Belhassen (Lyon, France), M. Nolin (Lyon, France), D. Vesque (Bois-Colombes, France), P. Devillier (Suresnes, France), G. Deslee (Reims, France), B. Housset (Créteil, France), H. Pegliasco (Marseille, France), E. Van Ganse (Lyon, France). Comparison of dual vs triple therapies in patients hospitalized for COPD in France: a claims data study. 4389

Member's Comments

No comment yet.

Related content which might interest you: Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses Source: ERJ Open Res, 4 (2) 00119-2017; 10.1183/23120541.00119-2017 Year: 2018 Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Chinese subgroup results from a study comparing single-inhaler triple therapy with dual therapy in COPD Source: International Congress 2017 – COPD management Year: 2017 Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population? Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Cost-effectiveness of single- vs multiple-inhaler triple therapy in a UK COPD population: INTREPID trial Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study. Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 Comparison of initial drug treatment of incident COPD patients with German treatment guidelines Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Factors related to discontinuous use of inhaled drugs in COPD patients: A population-based cohort study in Lazio (Italy) Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Retrospective review of studies shows that patients receiving salmeterol plus ICS have fewer serious asthma exacerbations vs patients on ICS alone, regardless of ethnic origin Source: Eur Respir J 2005; 26: Suppl. 49, 429s Year: 2005 Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018 A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015